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Abstract
Background: CTX-M is the most prevalent and rapidly growing type of the extended-spectrum β-lactamase (ESBL) family and CTX-
M1 is the most common type of blaCTX-M.
Objectives: The current study aimed at investigating the genetic diversity of CTX-M-1-producing Klebsiella pneumoniae circulating
in Semnan, Iran evaluated by multilocus variable-number tandem repeat analysis (MLVA).
Methods: A total of 110 isolates of K. pneumoniae were collected from different clinical samples. The antibiotic suceptibility and
double disk synergy test were determined according to CLSI (the clinical and laboratory standards institute) guidelines. The poly-
merase chain reaction (PCR) method was performed to detect CTX-M-1. The eight loci for MLVA genotyping were selected along with
the primers previously described.
Results: Imipenem, with 84.7% susceptibility, was the most effective antibiotic against K. pneumoniae. Seventy (63.63%) isolates had
ESBL positive results and 42 (60 %) of them were positive for CTX-M-1 gene. Totally, 28 MLVA genotypes were discriminated, evaluation
of diversity indexes (DIs) for eight loci showed that six different alleles were the most polymorphic and the most DI was 0.807.
Conclusions: The findings of the current study demonstrated heterogeneity among CTX-M-1-producing K. pneumonia strains. The
presence of CTX-M-1 in different MLVA types demonstrated that a certain clone is not responsible for spreading the isolates.
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1. Background
Klebsiella pneumoniae has emerged as an important
opportunistic pathogen that causes severe disease in
immunocompromised patients (1-3). During the past
decades, there was an increase in the incidence of infec-
tions caused by multidrug-resistant (MDR) species of Kleb-
siella. Infections caused by MDR K. pneumoniae are usually
associated with high mortality, morbidity, healthcare costs
and prolonged hospitalization. Production of extended-
spectrum β-lactamase (ESBL) is the basic reason for the
multidrug resistance in Gram negative bacteria through-
out the world. Since 1983 when the first ESBL enzymes
were described in Europe (Germany), there is an alarm-
ing increase in the incidence of ESBL-producing bacteria
(4-6). ESBL-producing K. pneumoniae strains are one of the
most important problems associated with nosocomial out-
break.
Among the various reported types of ESBL worldwide,
CTX-M is the most prevalent and rapidly growing member
of ESBL family (7, 8). CTX genes are disseminated and iden-
tified in hospitalized and outpatients worldwide. CTX en-
zymes are categorized into five important groups includ-
ing 1, 2, 8, 9, and 25. The CTX-M-1 is the most common type
of CTX-M detected in South America, Europe, and Asia (9,
10).
Genotyping methods are used to determine the clon-
ality of the isolates in nosocomial and household out-
breaks. Multilocus variable-number tandem repeat anal-
ysis (MLVA) is one of the molecular typing methods fre-
quently used in several studies to access genetic relations
and distinguishing bacterial pathogens. MLVA is a low cost,
rapid, and simple method based on polymerase chain re-
action (PCR) that provides the numerical data of the num-
ber of repetitions in a locus. The sequences known as
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variable number tandem repeat (VNTR) vary among differ-
ent strains in copy number. MLVA can provide transfer-
able information in the form of codes that can be saved
in database and exchanged between different laboratories.
This method, compared with other typing methods, re-
duced the handling of live bacteria (11-14).
2. Objectives
The current study aimed at evaluating the antimicro-
bial susceptibility patterns and ESBL phenotype in K. pneu-
moniae strains isolated from hospitalized patients. The
current study also aimed at determining CTX-M-type of
CTX-M-1 gene in clinical strains of K. pneumoniae isolated
from Semnan, Iran to assess their genetic diversity using
MLVA as a possible typing method.
3. Methods
3.1. Ethics Statement
The ethics committee of Semnan University of Medical
Sciences, Semnan, Iran approved the current study proto-
col (IR.SEMUMS.REC 1394.84).
3.2. Sampling
The current cross sectional study was conducted at
three hospitals in Semnan, Iran. A total of 110 K. pneumo-
niae strains were isolated from 95 urine (86.4%), 10 sputum
(9.1%), and five blood (4.5%) specimens.
3.3. Bacterial Identification
In order to identify K. pneumoniae, conventional bac-
teriological tests including Gram stain, lactose fermenta-
tion, hydrogen gas production from glucose, FeS produc-
tion, motility, indole production, sodium citrate utiliza-
tion, and urea utilization were performed (15). The veri-
fied isolates were preserved at -70°C in brain-heart infusion
broth with 30% (v/v) glycerol for further analysis.
3.4. Antibiotic Susceptibility Assay
The antibiotic susceptibility were determined ac-
cording to the clinical and laboratory standards insti-
tute (CLSI) guidelines (16). The used antibiotic disks
were cefotaxime (30 µg), nalidixic acid (30 µg), tetracy-
cline (30 µg), ciprofloxacin (5 µg), imipenem (10 µg),
trimethoprim-sulfamethoxazole (1.25/23.75 µg), and
amoxicillin-clavulanic acid (20/10 µg) (Rosco, Taastrup,
Denmark).
3.5. Screening of ESBL Phenotype
Double-disk synergy test was recommended by CLSI
(16) for phenotypic characterization of ESBL-producing iso-
lates. This test was used to confirm ESBL production
using ceftazidime (30 µg) and cefotaxime (30 µg) disks
with/without clavulanate (10 µg). Klebsiella pneumoniae
ATCC 700603 and Escherichia coli ATCC 25922 were used as
positive and negative controls, respectively. Positive ESBL
isolates showed increase in the inhibitory zone diameter
by≥5 mm around the disks with clavulanate versus those
of the ones without clavulanate.
3.6. DNA Extraction
Colonies of ESBL-producing K. pneumoniae were sus-
pended in TE (Tris-ethylenediaminetetraacetic acid) buffer
and genomic DNA was prepared by boiling method and
used as the template for PCR reactions as previously de-
scribed by Kuske et al. (17).
3.7. PCR Amplification to Detect CTX-M-1
The PCR was performed to detect CTX-M-1 using the
following primers as previously described (18): forward
primer: 5′ GACTATTCATGTTGTTGTTATTTC 3′, reverse
primer: 5′ TTACAAACCGTTGGTGACG 3′, PCR product size:
923 bp. Amplification reactions were performed in a total
of 25 µL volume containing 5 µL of 10X PCR buffer, 2.5 mM
MgCl2, 200 mM dNTPs, 1.5 unit of Taq polymerase, 10 pM of
each primer, and 1 µL of DNA template.
3.8. Multilocus Variable-Number Tandem Repeat Analysis
PCR conditions consisted of an initial activation for
genotyping of isolates with positive results for CTX-M-1
gene, the eight loci, including A, D, E, H, I, J, K, and L were se-
lected along with the primers as described by Turton (19).
For this analysis, PCR was performed for each locus sepa-
rately in a reaction mixture with total volume of 25µL, con-
taining 50 ng of DNA template, 1X PCR buffer, 2.5 mM of
MgCl2, 0.2 mM of each primer, and 0.5 U of Taq DNA poly-
merase. The PCR condition was as follow: 95°C for 15 min-
utes, 35 cycles of 94°C for 30 seconds, 58°C for 90 seconds,
72°C for 90 seconds, and a final extension at 72°C for 10 min-
utes. After performing PCR, the size of each locus was easily
determined on 1.5% gel agarose. The number of repeat for
each isolate was calculated by the following formula:
Number of repeat (bp) = size of each locus (bp) - flank-
ing regions (bp)/repeat size (bp)
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3.9. Statistical Analysis
The results were documented into Microsoft excel 2007
and uploaded into the web-based MLVA plus for analyz-
ing. Any difference in one or more VNTR locus was consid-
ered to indicate a distinct type. Simpson index of diversity
for each VNTR locus was calculated using V-DICE software
(Health Protection Agency, London).
4. Results
4.1. Antibiotic Susceptibility, ESBL, and CTX-M-1 Gene Detection
The findings of antibiotic resistant test showed that
the most effective antibiotic was imipenem (84.7% sus-
ceptibility). The frequency of resistance to trimethoprim-
sulfamethoxazole, cefotaxime, nalidixic acid, amoxicillin-
clavulanic acid, tetracycline, and ciprofloxacin were 52.3%,
65%, 39.3%, 30.2%, 29.1%, and 27.1%, respectively (Table 1). In
the current study, 70 (63.63%) isolates had ESBL positive re-
sults. The results obtained from PCR reaction using CTX-M-1
primers indicated that 42 out of 70 (60%) isolates were pos-
itive. PCR product for CTX-M-1 gene is shown in Figure 1.





67 (60.9) 10 (9.1) 33 (30)
Trimethoprim-
sulfamethoxazole
52 (47.3) 0 58 (52.7)
Tetracycline 77 (70) 1 (0.9) 32 (29.1)
Imipenem 93 (84.6) 4 (3.6) 13 (11.8)
Ciprofloxacin 79 (71.8) 1 (0.9) 30 (27.3)
Nalidixic acid 55 (50) 12 (10.9) 43 (39.1)
Cefotaxime 62 (56.4) 1 (0.9) 47 (42.7)
4.2. Multilocus Variable-Number Tandem Repeat Analysis
MLVA was performed on 42 K. pneumoniae isolates, us-
ing eight loci. The PCR products of these loci are shown in
Figure 2. Totally, 28 MLVA genotypes were discriminated.
Isolates were classified into two clonal complexes, clonal
complex 1 including six isolates and clonal complex 2 in-
cluding three isolate; furthermore, 19 singletons were dis-
tinguished in the isolates. Minimal spanning tree of these
isolates is shown in Figure 3.
4.3. Evaluation of Clonality in the Studied Isolates
In the studied isolates, two clonal complexes (CCs) and
19 singleton isolates were categorized. The CC1 comprised
six isolates and CC2 comprised only three isolates.
Figure 1. Electrophoresis of CTX-M-1 gene PCR product on 2% agarose gel; lane M: a
100-bp ladder; lane 1, 2, 4, and 5: positive samples; lane 3: negative sample; lane 6:
positive control; lane 7: negative control.
4.4. Reviewing Simpson Diversity Index for Each Locus
Locus J with six replicates and diversity index (DI) of
0.807 had the most differentiation power compared with
the other loci used. Locus A with five replicates (DI = 0.768)
ranked second in terms of differentiation power, followed
by locus K with five replicates (DI = 0.750), locus H with
five replicates (DI = 0.737), locus L with four replicates (DI
= 0.704), and E with four replicates (DI = 0.628). Locus D
with three replicates and DI = 0.475 ranked the lowest dif-
ferentiation power compared with other loci.
5. Discussion
Klebsiella pneumoniae is one of the most important
causative agents of several infections such as blood stream,
wound, pneumonia, and urinary tract infection (20, 21).
The emergence of ESBL-producing Gram-negative bacilli,
especially K. pneumoniae as serious pathogen, is reported
worldwide and is rapidly changing over time (22-24). In
the current study, ESBL positive phenotype was observed in
42 isolates. In the current study, similar to previous stud-
ies, the most ESBL-producing K. pneumoniae were obtained
from urine (25, 26). Consumption of large amount of
third-generation cephalosporins by patient could describe
the high prevalence of ESBL-producing K. pneumoniae (27).
Since the ESBL genes are located on a mobile element,
ESBL positive isolates showed a high rate of resistance to
non-β-lactam antibiotics (28). Imipenem and meropenem
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Figure 2. Gel electrophoresis of PCR products obtained from 8 VNTR loci (E, D, H, I, J, L, A, K) on CTX-M-1-producing Klebsiella pneumoniae
and carbapenem were very active antibiotics against ESBL-
producing K. pneumoniae. In the current study, imipenem
with 84.7% susceptibility was the most effective antibiotic
against K. pneumoniae.
The incidence of CTX-M-type ESBL-producing Klebsiella
rapidly increased worldwide. The CTX-M enzymes are clas-
sified into five major groups based on CTX-M amino acid se-
quences. The occurrence of these CTX-M genotypes greatly
varies among ESBL-producing isolates geographically (9,
29). Previous studies revealed that CTX-M-1 was the most
common one among ESBL gene families (30-33). Forty-two
out of 70 ESBL-producing Klebsiella isolates in these study
carried CTX-M-1. Molecular typing is a reliable tool to study
nosocomial infections. Since in recent years a significant
increase of ESBL-producing K. pneumoniae is observed in
hospital settings with the risk of outbreak, there is a need
for a rapid and low cost typing method (34). Among the
various typing methods, PFGE is accepted for typing of bac-
teria. However, to choose a reliable typing method in labo-
ratory settings, several parameters such as interpretation
time, costs, and complexity of performance should be con-
sidered. Since PFGE is time-consuming and technically de-
manding, an alternative method such as MLVA, which is
easy-to-perform, cost-effective, and highly reproducible re-
ceived attention (4-6, 11).
Naseer et al. applied MLVA method for genotyping E.
coli carrying CTX-M-type ESBL (11). In the current study,
42 CTX-M-1 producing isolates were included to determine
clonal relationship using MLVA method. In the current
study, size of PCR products can be easily analyzed on
agarose gel without any complicated requirement. Out of
a total 42 CTX-M-1-producing K. pneumoniae isolates in the
current investigation, MLVA revealed 28 distinct patterns
of K. pneumoniae isolates; given that the 28 MLVA genotypes
were isolated from three hospitals in one year, it can be
concluded that clonal complexes with a small number of
isolates in each can indicate the entry of a new bacterium
in the ward. The isolates identified as singleton are pos-
sibly the bacteria that have entered the ward by the pa-
tient, the visitors or medical personnel. These isolates were
not established in the ward. The current study findings
demonstrated heterogeneity among CTX-M-1-producing K.
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Figure 3. Minimal Spanning Tree of Klebsiella pneumoniae Isolates
pneumoniae isolates. Evaluation of diversity indexes for
VNTR loci showed that VNTR-J with six different alleles was
the most polymorphic and the highest diversity index of
0.807, locus D was the least variable among the current
study strains with two alleles and diversity index of 0.475.
6. Conclusions
The presence of CTX-M-1 in several different MLVA types
demonstrated that one specific clone was not responsible
for spreading the isolates. It seems that mobility and hori-
zontal transfer occurred among these isolates.
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